Table 1.
Clinical and Pathologic Data for Thirty-Three Subjects with Papillary Thyroid Cancer
Total(n=33) | BRAFWT(n=16) | BRAFV600E(n=17) | ||
---|---|---|---|---|
Characteristics | No. (%) | No. (%) | No. (%) | p-Valuea |
Sex (female) | 29 (87.8) | 15 (93.8) | 14 (82.4) | ns |
Age (years) | ||||
Median (range) | 49 (22–75) | 48 (22–72) | 54 (30–75) | nsb |
<45 years | 10 (30.3) | 4 (25) | 6 (35.3) | |
>45 years | 23 (69.7) | 12 (75) | 11 (64.7) | ns |
Primary tumor | ||||
T1-2 | 26 (78.8) | 12 | 14 | |
T3-4 | 7 (21.2) | 4 | 3 | ns |
Lymph node status | ||||
Nx, N0 | 21 (63.6) | 13 | 8 | |
N1 | 12 (35.2) | 3 | 9 | 0.07 |
TNM stage | ||||
1 | 20 (60.7) | 10 | 10 | |
2 | 2 (6) | 1 | 1 | |
3 | 3 (9.1) | 2 | 1 | |
4 | 8 (24.2) | 3 | 5 | ns |
Fisher's exact test except as indicated.
Unpaired Student's t-test.